Todd Wandstrat is a seasoned medical affairs leader with over 38 years of transformative experience in the biotechnology and pharmaceutical industries. Renowned for his expertise in managed markets, health economics and outcomes research (HEOR), and field medical team leadership, Todd has successfully contributed to more than 35 product launches across diverse therapeutic areas. His professional journey is defined by a relentless commitment to integrating payer and patient perspectives into early-stage asset development, ensuring both innovative therapies and accessible care.
Todd’s career spans executive leadership roles in globally recognized organizations, where he has cultivated strategic alliances with healthcare decision-makers, thought leaders, and payers. As Founder and President of Magnum Futurum Advisors, LLC, he provides strategic consulting to help biotech and pharmaceutical companies maximize their asset value propositions. Todd specializes in early integration of real-world evidence (RWE) and HEOR insights to streamline access strategies and foster lifecycle success.
A hallmark of Todd’s career is his ability to lead multidisciplinary teams in dynamic environments. His tenure at Pyros Pharmaceuticals and Trevena, Inc. demonstrates his acumen in building and managing medical science liaison teams, developing value-driven communication platforms, and leading pharmacoeconomic studies. By aligning medical, payer, and regulatory strategies, Todd ensures that therapies meet the needs of both providers and patients while achieving commercial success.
Todd’s global experience includes leading global field medical teams across the Americas, Asia-Pacific, and Europe, where he tailored strategies to meet regional needs while maintaining global alignment. His tenure at Arena Pharmaceuticals highlighted his ability to optimize clinical trial enrollment and enhance cross-functional collaboration during unprecedented challenges, such as the global pandemic. Todd’s leadership style emphasizes coaching, mentoring, and fostering professional growth within his teams.
In addition to his corporate accomplishments, Todd has contributed significantly to academia. As an Associate Professor at West Virginia University, he spearheaded the development of pediatric pharmacotherapy curricula and established a research center focused on pharmacoeconomics and outcomes research. His passion for education is reflected in the success of his mentees, with an 80% placement rate in competitive roles.
Todd’s professional philosophy centers on the seamless integration of medical affairs, payer engagement, and patient advocacy. His extensive knowledge of therapeutic areas, including oncology, rare diseases, immunology, and neuroscience, positions him as a thought leader in the evolving landscape of healthcare. By fostering partnerships across sectors, Todd has consistently advanced initiatives that deliver measurable impact.
Todd’s contributions extend beyond his professional roles to volunteering and community involvement. For over a decade, he has supported the Freestore Foodbank as a committee member, championing innovative strategies to combat food insecurity. This commitment underscores his belief in addressing the social determinants of health to create lasting change.
A dedicated lifelong learner, Todd holds a Doctor of Pharmacy (PharmD) and a Bachelor of Science in Pharmacy from the University of Cincinnati, complemented by a Pediatric Pharmacotherapy Residency at the University of Tennessee Health Science Center. His academic foundation has fueled his innovative approach to integrating clinical, academic, and market access strategies.
Todd Wandstrat’s biography is a testament to his unwavering dedication to improving patient outcomes through innovation, collaboration, and strategic leadership. With a career marked by impactful contributions to medical affairs and global healthcare systems, Todd continues to drive transformative change in the industry.
Character:
Todd Wandstrat exemplifies integrity, collaboration, and a steadfast commitment to advancing healthcare for patients worldwide. His dedication to mentorship, professional growth, and community service underscores his belief in fostering meaningful and lasting impact.
Knowledge:
With extensive expertise across therapeutic areas such as oncology, immunology, and rare diseases, Todd possesses a deep understanding of medical, economic, and regulatory landscapes. His ability to integrate HEOR, payer insights, and clinical strategies ensures comprehensive solutions that align with both patient and market needs.
Strategic:
Todd is a results-oriented leader who aligns cross-functional strategies to achieve innovation and market access for diverse healthcare products. His ability to anticipate challenges and balance short-term objectives with long-term growth ensures success in dynamic and complex environments.
Communication:
A skilled communicator, Todd bridges diverse stakeholders, from payers and healthcare professionals to academic and corporate teams, to build consensus and foster partnerships. His clear, actionable insights and collaborative approach consistently drive impactful outcomes.
